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                                 INTRODUCTION
      Emotion, perception and past experience all affect an individual’s 
response to noxious stimuli. Patient’s attitudes and concerns about 
postoperative pain need to be addressed preoperatively. Early 
interventions influence long-term outcomes. Because of the multiplicity 
of mechanisms involved in post operative pain, a multimodal analgesia 
regimen, with a combination of opioid and non-opioid analgesic drugs is 
often used to enhance analgesic efficacy and reduce opioid requirements 
and side effects. Preemptive analgesia was assumed to reduce risk of 
developing persistent postoperative pain1. 
      Peripheral tissue injury provokes peripheral sensitization and central 
sensitization1,2. These changes contribute to the post injury pain 
hypersensitivity state which manifests as an increase in the 
responsiveness to noxious stimuli and a decrease in the pain threshold, 
both at the site of injury and in the surrounding uninjured tissue2,3. The 
preemptive treatment could be directed at the periphery, at inputs along 
sensory axons and at central neurons. Different treatment regimen could 
be used at different levels of sensory inputs2,3.
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   Gabapentin, a structural analogue of gamma-amino butyric acid, has 
been used as an anticonvulsant and antinociceptive drug but its mode of 
action is not well understood4. In addition it has been effective in 
neuropathic pain, diabetic neuropathy, post herpetic neuralgia and reflex 
sympathetic dystrophy. Pretreatment with gabapentin can block the 
development of hyperalgesia. Studies have demonstrated that mechanical 
hyperalgesia surrounding the wound in post operative patients and 
experimentally, heat-induced secondary hyperalgesia share a common 
mechanism and the central neuronal sensitization contributes to 
postoperative pain. Gabapentin has a selective effect on the nociceptive 
process involving central sensitization.
      In our institution we chose to study the efficacy of oral Gabapentin  
administered preoperatively on the  postoperative pain relief and it’s 
influence on the postoperative Epidural analgesic requirement in patients 
undergoing elective lower limb orthopaedic procedures 
undercombinedspinalepidural anaesthesia
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AIMS AND OBJECTIVES
1. To evaluate the preemptive analgesic efficacy of gabapentin given 
orally for postoperative epidural analgesia requirement in patients 
undergoing elective orthopaedic lower limb surgeries.
2. To evaluate the hemodynamic response of oral gabapentin
3.        To evaluate the side effect profile of oral gabapentin
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DEFINITION OF PAIN
The international Association for the study of pain(IASP) defines pain as 
“an unpleasant sensory and emotional experience associated with actual 
or potential tissue damage or described in terms of such damage”
PHYSIOLOGY OF PAIN
Nociception is conveyed from periphery to the brain at three levels:the 
peripheral nociceptor, the spinal cord and the supra- spinal levels.
They are of two types - physiological and pathological pain. 
I. PHYSIOLOGICAL PAIN :is  produced  by  stimulation  of  high 
threshold  thermo/chemical  nociceptors,  which  transmit  via  fast 
conducting A delta fibres. They enter the dorsal horn of the spinal cord 
and synapse at laminae I & V.
II. PATHOLOGICAL PAIN : originates from stimulation of the 
high threshold polymodal nociceptors to mechanical,chemical and 
thermal stimuli and are transmitted via slow conducting unmyelinated C 
fibres. These synapse at laminae II& III (substantia gelatinosa) of the
 dorsal horn. The second order neurons are either nociceptive (substantia 
gelatinosa) or wide dynamic range (WDN) neurons( in  laminae V &VI) 
that respond to a wide range of noxious and non – noxious input. Both 
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pathways ascend up the spinal cord via the spinothalamic tracts  to the 
thalamus, which synapse and project on to the somatosensory cortex. 
Inhibitory inter-neurons in the substantia gelatinosa prevent activation of 
the dorsal root ganglia. Inter-neurons can be activated by A Delta and 
inhibited by the A beta and C fibre activity. Pain can be gated out by 
stimulating large A beta fibres in the painful area. This is the working 
 mechanism behind the transcutaneous electrical nerve stimulation. The 
descending inhibitory pathways originate at the level of the cortex and 
thalamus, and descend via the brainstem (periaqueductal grey) and the 
dorsal columns to terminate at the dorsal horn of the spinal cord. 
Neurotransmitters noradrenaline,  serotonin and the endogenous opiods  
are released to provide antinociception.      
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                                       NEURAL PAIN PATHWAYS
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                 PREEMPTIVE ANALGESIA
Definition : “what is administered before surgical incision, what prevents 
establishment of central sensitization resulting from incisional injury 
(only intraoperative) or what prevents central sensitization resulting from 
incisional and inflammatory injuries (intra-operative and postoperative 
period)”. 
Surgical tissue injury is known to produce neuroplastic changes leading 
to spinal sensitization and the expression of stimulus-evoked hyperalgesia 
and allodynia. Poorly controlled acute postoperative pain may be an 
important factor in the development of pathologic long-term chronic pain. 
Prevention of central sensitization and control of postoperative pain may 
decrease the incidence of chronic pain. In case of inflammatory pain there 
is release of inflammatory and pro-inflammatory cytokines from the cells 
that sensitize or stimulate free nerve endings, initiate the coagulation 
cascade and activate the immune system. The ensuing lowering of the 
activation of the receptors for pain at the site of injury results in the 
bombardment of the spinal cord with continuous noxious input via A-
delta and c-fiber. Additionally, under the stress of intense inflammatory 
pain, A-alpha and A-beta fibers are induced to participate in the 
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transmission of pain signals. This is significant, given that their input is 
not filtered in the spinal cord in the same way as A-delta and c-fibers, nor 
can it be dampened or modified as effectively with classic analgesic 
medications such as opioids. It is believed that the continuous nature of 
the input provokes changes in the chemical milieu in the spinal cord and 
triggers structural reorganization that raises the potential for establishing 
naturopathic pain. Thus, whenever there is enhanced noxious input, there 
is an induction of decreased central inhibition that would ordinarily 
modify the input and the subsequent central nervous system response. 
      This is where preemptive analgesia plays an important role. 
Confining the definition of preemptive analgesia to only the intra 
operative period may not be clinically relevant or appropriate because the 
inflammatory response may last well into the postoperative period and 
continue to maintain central sensitization. Maximal clinical benefit is 
observed when there is complete blockade of noxious stimuli with 
extension of this block into the postoperative period.
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                                    POST OPERATIVE PAIN
Effects of  Post operative  Pain: 
Post operative pain can affect all organ system and includes 
 Respiratory  -reduced  cough,  atelectasis,  sputum  retention 
and hypoxemia.
 Cardiovascular - increased  myocardial  oxygen 
consumption and ischemia 
 Gastrointestinal - decreased gastric emptying,  reduced gut 
motility and constipation
 Genitourinary - urinary retention
 Neuroendocrine  - hyperglycemia,  protein  catabolism  and 
sodium retention. 
 Musculoskeletal - reduced  mobility  pressure  sores  and 
increased risk of deep vein thrombosis. 
 Psychological - Anxiety and fatigue. 
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Non-Pharmacological methods of pain relief:
Preoperative  explanation  and  education,   Relaxation  therapy, 
Hypnosis, cold or heat,  Splinting of wounds,  Transcutaneous electrical 
nerve stimulation (TENS). 
Pharmacological Methods of pain relief:
Simple Analgesia - paracetomol (parenteral / oral)
Non - steroidal Anti - inflammatory agents - (parenteral / oral)
Opiods  -  oral,  subcutaneous,  intramuscular,  intravenous,  Patient-
controlled Analgesia (PCA), Epidural or intrathecal. 
Local anaesthetic Agents -  Wound infiltration, nerve (or) nerve plexus 
blockade, epidural, intrathecal
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BENEFITS OF EPIDURAL ANALGESIA
Use of perioperative epidural anaesthesia and analgesia especially 
with  a  local  anaesthetic  -  based  analgesic  solution  can  attenuate  the 
pathophysiologic  response  to  surgery  and  may  be  associated  with  a 
reduction  in  mortality  and  morbidity  compared  with  analgesia  with 
systemic opoids. 
Rodgers  et  al  (38)  demonstrated  through  a  meta  -  analysis  of 
randomized data (141 trials  enrolling 9559 subjects)  that  perioperative 
use of neuraxial anaesthesia and analgesia versus general anaesthesia and 
systemic opiods reduced overall mortality by approximately 30%. Use of 
epidural  analgesia  can  decrease  the  incidence  of  postoperative 
gastrointestinal, pulmonary and cardiac complications. 
The  use  of  intra  operative  regional  anaesthesia  decreases  the 
incidence of postoperative hypercoagulable -  related events  (e.g.  Deep 
vein thrombosis, pulmonary embolism. vascular graft failure).
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POSTOPERATIVE ANALGESIA IN ORTHOPAEDICS
Postoperative pain is a major concern after orthopaedic lower limb 
surgery. Moderate to severe at rest, it is exacerbated on movement and 
particularly after hip and knee surgery and by severe reflex muscular 
spasms. This not only causes patient discomfort but also compromises the 
early physical therapy, the most influential factors are rapid postoperative 
rehabilitation and ambulation. 
Postoperative  pain  relief  can  be  achieved  by  a  number  of 
techniques such as intravenous patient controlled analgesia (PCA) with 
morphine  or  non-steroidal  anti  -  inflammatory  drugs  or  epidural 
analgesia.  Effective  analgesia  with  epidural  or  peripheral  blockade 
reduces  narcotic  requirements,  provides  better  analgesia,  reduces 
catabolism  and  results  in  improved  rates  of  rehabilitation  after 
orthopaedic lower limb surgeries. 
The  benefit  of  effective  postoperative  analgesia  in  orthopaedic 
surgeries was made evident by the fact that it facilitates early ambulation 
which is beneficial in the prophylaxis of deep vein thrombosis, which is a 
common problem  encountered in orthopaedics. Postoperative modalities 
like pneumatic compression boots, foot pumps, foot exercises, aspirin and 
low dose warfarin (Started the day after surgery) can be safely used in 
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conjunction  with  epidural  anaesthesia  to  reduce the incidence  of  deep 
vein thrombosis. 
                           GABAPENTIN
Initially introduced in 1994 as an antiepileptic drug (AED).
CHEMICAL STRUCTURE:
     Gabapentin [l-aminomethyl cyclohexane acetic acid] is a structural 
analogue of gamma-aminobutyricacid (GABA).
                         
 Has a GABA molecule covalently bound to a lipophilic cyclohexane 
ring. Gabapentin, with its centrally active GABA agonist property and 
lipid solubility crosses the blood-brain barrier
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MECHANISM OF ACTION:
         Gabapentin was developed as a direct agonist but does not have 
high affinity for GABA-A or GABA-B receptors The mechanism of 
anticonvulsant action of gabapentin is unknown. Despite its design as a 
GABA agonist, gabapentin does not mimic GABA when iontophoreticaly 
applied to neurons in primary culture. Gabapentin may influence the 
synthesis and release of GABA9, but it does not affect the uptake and 
metabolism of endogenous GABA10. 
     The gabapentin specific binding site was identified as the α2-theta 
subunit of voltage dependent calcium channels11 has high affinity for the 
alpha 2 delta one subtype12. Gabapentin can inhibit high threshold 
calcium currents in cultured sensory neurons13. It inhibits excitatory 
amino acid release through its interaction with the calcium channels and 
reduces hyperalgesia14. Gabapentin does not affect calcium currents of 
T,N and L type calcium channels in the dorsal root ganglion cells15. 
     Gabapentin has not been found to reduce sustained repetitive firing of 
action potentials16. The exact mechanism by which gabapentin exerts its 
analgesic effect is not yet known. 
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PHARMACOKINETICS:
     Oral administration of gabapentin is well absorbed and is not 
metabolized in the humans. It is not bound to plasma proteins. It is 
excreted unchanged by kidneys in the urine. Half-life of gabapentin, 
when used as mono therapy is 4-6 hours. It has no known interactions 
with other antiseizure drugs. 
     In renal failure gabapentin should be titrated according to the 
creatinine clearance and can be given with hemodialysis. 
PREPARATIONS:
They are available only in the oral form 
(1) Tablet 
(2) Capsule 
(3) Oral solutions  
DOSAGE: 5-20 mg/kg
 USES:
1. Partial seizures 
     2.Post herpetic neuralgia17 
     3. Painful diabetic neuropathy18 
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4. Gullain-Barre syndrome19 
5. Complex regional pain syndrome 20 
6. Phantom limb pain21 
7. Postoperative pain 
8. Mixed neuropathic pain 
ADVERSE EFFECTS:
      Gabapentin is usually well tolerated. The most common side effects 
are: 
(1) Somnolescence 
(2) Dizziness
(3) Ataxia 
          (4) Fatigue  
     These effects are usually mild to moderate in severity but resolve 
within two weeks of onset during continued treatment. The 
contraindications in using gabapentin are hypersensitivity and lactation. 
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                                            BUPIVACAINE
Bupivacaine was introduced by Boaf Ekenstam in 1963. 
Chemical  Structure  :  Bupivacaine  hydrochloride  is  2-  piperidine 
carboxamide  1-butyl-N-(2,6  dimethlphenyl)  monohydrochloride,  a 
monohydrate  a  white  crystalline powder  that  is  freely  soluble  in  95% 
ethanol, soluble in water and slightly soluble in chloroform or acetone.
Bupivacaine  is  related  chemically  and  pharmacologically  to  the 
amide local anaesthetics. It is a structural homologue  of mepivacaine. 
Presentation : Bupivacaine hydrochloride is  available in sterile isotonic 
solution with and without epinephrine 1:2,00,000 for injection. 0.25%, 
0.5%, 0.75% concentration containing 2.5mg/ml  5mg/ml,  7.5mg/ml  of 
bupivacaine  hydrochloride  respectively.  Sodium  chloride,  sodium 
C18 H28 N2 O 
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hydroxide + hydrochloric acid for pH adjustment. Methylparaben 1mg/ml 
added as preservative. 0.5% (Hyperbaric) solution containing 80mg/ml of 
glucose (with a specific gravity of 1.026) - intrathecal use. 
Mechanism of Action: 
Local anaesthesics diffuse in their nonionized form through neural 
sheaths  and  the  axonal  membrane  to  the  internal  surface  of  cell 
membrane sodium ion channels where they combine with hydrogen ions 
to form a cationic species which enters the internal opening of the sodium 
ion channel and combines with a receptor. This produces blockade of the 
sodium  ion  channel  thereby  decreasing  sodium  conductance  and 
preventing depolarisation of the cell membrane. 
Pharmacological actions:
a) CNS  :  The  principal  effect  of  bupivacaine  is  reversible  neural 
blockade,  this leads to a characteristically biphasic effect  on the 
CNS. 
 Initially  excitation  :  Lightheadedness,  dizziness,  visual 
and  auditory  disturbances  and  seizures  occurs  due  to 
blockade o inhibitory pathways in the cortex.  
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 With increasing doses CNS depression :  Depression of 
both facilitatory and inhibitory pathways occur leading to 
central  nervous  system  depression  (drowsiness, 
disorientation and coma)
 Local  anaesthetic  agent  block  neuromuscular 
transmission when administered intra-arterially (fomation 
of  neurotransmitter,  receptor  and  local  anaesthetic 
complex which has negligible conductance)
b ) CVS : It binds specifically to myocardial proteins. In toxic 
concentrations, the drug decreases the peripheral vascular resistance and 
myocardial  contractility  producing  hypotension  and  possibly 
cardiavascular collapse. (Cardiotoxic only in high doses).
Routes of Administration: Topical, Infiltration, Intrathecal, Epidural. 
Doses : 2mg/ kg (with or without adrenaline)
Pharmacokinetics : 
Absorption : The absorption of local anaesthetic agents is related to 
1. The  site  of  injection  (intercostal  >  epidural  >  brachial 
plexus > subcutaneous). 
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2. The dose-linear relationship exists between the total dose 
and the peak blood concentration achieved. 
3. Addition of  adrenaline to  bupivacaine  solutions  doesn't 
influence the rate of systemic absorption as
- the drug is highly lipid soluble and therefore uptake into 
fat is rapid. 
- the drug has a direct vasodilatory effect. 
Distribution : 95% protein bound in plasma volume of distribution - 41-
103 litres.  
Metabolism : Liver by N - dealkylation primarily to pipcolyloxylidine. 
N-desbutyl  bupivacaine  and 4-hydroxy bupivacaine  are 
also formed. 
Excretion : 16% - unchanged form
5% - Urine as pipcolyloxylidine
Clearance rate - 0.47 litres/ min
Elimination half life - 0.31- 0.61 hours. 
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Pharmacodynamics : PKa  of  bupivacaine  is  8.1,  Heptane  :  Buffer 
partition coefficient 27.5. 
The onset  and duration of  conduction blockade is  related to the 
pka, lipid solubility and the extent of protein binding of the drug. 
- A low pka and high lipid solubility are associated with a rapid 
onset time. 
- High  degree  of  protein  binding  is  associated  with  a  long 
duration of action. 
Toxicity / side effects:
i) Allergic reactions to amide - type local anaesthetics. 
ii) No longer recommended for intravenous regional blockade - as 
refractory cardiac depression leading to death has been reported. 
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                             REVIEW OF LITERATURE
Role of gabapentin as preemptive Analgesic in Patients 
Undergoing Total Abdominal Hysterectomy in combined 
spinal epidural anaesthesia.IJA 2008 52(4) 428-431
Anil Verma,Sangeeta Arya et al conducted a study to evaluate the role 
of gabapentin as preemptive analgesic in patients undergoing total 
abdominal hysterectomy under combined spinal epidural anaesthesia and 
the epidural bolus requirements for pain relief in the postoperative period 
was noted.Total numbers of epidural  boluses were significantly less in 
gabapentin  group They concluded that preemptive  use of gabapentin 
300mg orally significantly reduces the number of postoperative epidural 
bolus requirement and postoperative pain in patients undergoing total 
abdominal hysterectomy under combined spinal epidural anaesthesia.
Effect of oral gabapentin on postoperative epidural 
Analgesia in patients undergoing elective lower 
extremity procedures:British Journal of Anaesthesia 96 (2): 242–6 
(2006)
 Turan a et al 2006 hypothesized that gabapentin might be a useful 
adjuvant for postoperative analgesia provided with patient-controlled 
epidural analgesia (PCEA) in patients undergoing lower 
extremity surgery procedures. Postoperative assessments included verbal 
rating scale scoring for pain and sedation, PCEA usage, quality of 
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recovery assessment, times of GI function recovery, and patient 
satisfaction scoring for pain management. Pain scores, PCEA bolus 
requirements and paracetamol (mg) consumption were significantly lower 
in the gabapentin-treated patients than in the control group. Patient 
satisfaction with postoperative pain management at 24 h was better in 
gabapentin-treated patients .He concluded that Oral gabapentin (1.2 g /
day) as an adjunct to epidural analgesia decreased pain and analgesic 
consumption. 
MONTAZERI ET  AL (25)
 Singapore journal of anaesthesia 07 demonstrated the pre-emptive use of
gabapentin could reduce postoperative pain and morphine consumption in 
patients after lower extremity orthopaedic surgery . He
concluded that the Pre-emptive use of gabapentin 300 mg orally 
significantly decreases postoperative pain and rescue analgesic 
requirements in patients who undergo lower extremity orthopaedic 
surgery.
 Dirks et al 200233  Anaesthesiology 2002 concluded that a single dose 
of 1,200 mg oral gabapentin resulted in a substantial reduction in 
postoperative morphine consumption and movement-related pain after 
radical mastectomy, without significant side effects. 
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Pandey et al 200422 CJA compared the effects of gabapentin, tramadol 
and placebo on postoperative pain scores and opioid requirement. 
      Postoperatively the three groups were evaluated for pain scores 
through Visual Analogue Score (VAS) and then total consumption of 
fentanyl by all the three groups were compared. There was significantly 
less consumption of fentanyl in the Gabapentin group  than tramadol and 
placebo group 
  Pandey et al 2004 23 Canadian Journal of Anaesthesia 2004; 52: 
986 -989. He studied the effects of preemptive gabapentin on 
postoperative pain and total amount of fentanyl consumption. The 
postoperative pain score evaluated using pain scale and total amount of 
fentanyl consumption was recorded. He concluded that fentanyl 
consumption is significantly lesser in gabapentin group compared to the 
placebo group.
   Turan et al 200424    Anaesthesia and analgesia, conducted a Study to 
compare the effect of  oral gabapentin and placebo and the requirement of 
rescue analgesia in patients undergoing elective total abdominal 
hysterectomy.Pain was evaluated by VAS and the total amount of rescue 
medication needed was statistically evaluated in both the groups. There 
was significant reduction in VAS and requirement of rescue medication 
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with p<0.05. 
      Dierking G et al 200429    Acta Anaesthesiologica scandinavica,
 2004; 48: 322-327. Conducted a study in which eighty patients were 
given gabapentin 1200mg or placebo. Analysis of VAS at rest and 
mobilization was done. Postoperative opioid requirement in the 
gabapentin group was significantly low with p<0.001. 
      Menigaux C et al 200527 Anaesthesia and analgesia 2005; 
100:1394-1399  studied the effects of preoperative gabapentin on 
preoperative anxiety and postoperative analgesia with early knee 
mobilization. Forty patients were studied under gabapentin and 
placebo group. VAS, postoperative opioid requirement and maximal 
effect achieved was observed in the postoperative period. Gabapentin was 
found to have anxiolysis, postoperative analgesia and early knee 
mobilization. 
      Mikkelsen S et al 200630   Acta   Anesthesiologica 
Scandinavia,2006; 50: 809-815. Conducted a study to evaluate the 
effects of single dose gabapentin versus placebo on postoperative pain 
and morphine consumption after mastectomy      Postoperative pain score 
evaluated using four point verbal rating scale. There was significant 
reduction in requirement of morphine during the postoperative period in 
the gabapentin group with a p<0.003. 
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MATERIALS AND METHODS
The study population consisted of 40 ASA I & II patients in the age 
group of 18 years to 65 years admitted to undergo elective orthopaedic 
lower limb surgeries at Govt. Stanley Hospital, Chennai during the period 
of January 2009 to june 2009. After getting approval by the institutional 
ethics committee and after obtaining written informed consent from each 
patient the study was conducted. 
Inclusion Criteria:
1.Age group 18-65 yrs
2.ASA I &ASA II
3.Elective lower limb orthopaedic surgeries
4.Duration of surgery between 2:00 to 2:30 hours
Exclusion Criteria:
1. Emergency surgery
2. Pre existing neurologic disorders
3. Liver & Renal disorders
4. Psychiatric illness 
5. Local infection at lumbar area
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6. Coagulation  defects  &  patients  on 
anticoagulation 
Preoperative Assessment:
All the patients were examined prior to surgery. Routine clinical 
examination,  Biochemical  investigations,  Electrocardiogram  and  chest 
X-ray were examined thoroughly for the conduct of anaesthesia. 
Conduct of Anaesthesia:
Patients were allocated randomly in a double binded fashion into 
two equal groups (20 in each group). Group P (placebo) received a tablet 
of  alike  looking  placebo(Vitamin  C),  Group  G(Gabapentin)  received 
300mg tablet of  gabapentin 90 minutes prior to anaesthesia with sips of 
water.
No premedication  was  given.  On arrival  in  the  operating  room, 
baseline  cardiorespiratory  parameters  viz.,  Heart  rate  (HR),  Systolic 
blood pressure  (SBP),  Diastolic  Blood Pressure  (DBP),  Mean Arterial 
Pressure (MAP) and Respiratory rate (RR) were recorded.
A good intravenous access was started at the non-operative side 
forearm  of  the  patient  using  18  G  IV  cannula.  Preloading  with 
crystalloids (10 ml/kg) was done. 
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With the patient in sitting posture, after informing the procedure to 
the  patient  &  under  strict  aseptic  precautions,  epidural  space  was 
identified at L2-L3 or L1- L2 interspace using 16 G Tuohy needle by 
Loss of Resistance technique. 18 G epidural catheter was threaded in a 
cephalad direction & 3-4 cm catheter length was kept inside the epidural 
space. Test dose of 3 cc of 1.5% lignocaine with adrenaline (5µg/ml) was 
given.  spinal  anaesthesia  was  performed in  L3-L4 space  and 3 c.c  of 
0.5% bupivacaine hyperbaric was injected. Epidural catheter was fixed & 
secured with tapes.
A standard anaesthetic technique was followed in all patients. Any 
surgery prolonging more than 150 minutes or those requiring  intra op 
requirement of activation of epidural was excluded from the study.
Intra-operatively  the  patient  was  monitored  with  Electro 
cardiogram (ECG), Non-invasive blood pressure (NIBP), Pulseoximetry 
(SPO2) and urine output. During the entire operative procedure Heart rate 
(HR), Systolic Blood pressure (SBP), Diastolic Blood pressure (DBP), 
mean  arterial  pressure  (MAP),  respiratory  rate  (RR)  was continuously 
monitored & recorded every 5 minutes. All patients were given oxygen 
supplementation (4-5 L/min) through hudson's face mask. All the patients 
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were  given  anxiolytic  -  Injection  Midazolam  0.05  mg/kg.  IV.  No. 
intravenous opiod analgesics were supplemented during the study. 
Intravenous fluid  management  was  done based on mean arterial 
Blood pressure & surgical blood loss. 
Post-operative Monitoring:
Postoperatively the patient  was transferred to the recovery room 
and observed continuously for 60 minutes. Patient was then shifted to the 
postoperative  ward  where  pulse  rate,  systolic  blood pressure,  diastolic 
blood  pressure  and  respiratory  rate,  occurance  of  headache,  dizziness 
were recorded at 2, 4, 8, 12, 24 hour intervals. The patients were assessed 
by the same observer in the postoperative period who was blinded for the 
group assignment. The intensity of pain was measured by using the verbal 
rating pain scale at 2, 4, 8, 12, 24hour intervals.
Pain Score (Verbal Rating Scale)
Grade 0 - No complaint of pain
Grade 1 - Patient complaints of pain but tolerable 
                               (mild pain)
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Grade 2 - Patient complaining of severe pain and demands    
                               relief    (Moderate pain)
Grade 3 - Patient restless and screaming with pain. 
                               (Severe pain)
When the patient complained of pain i.e., the pain intensity was 
assessed   based  on  Verbal  Rating  Scale,  if  the  pain  score  reaches  1, 
patient was given an epidural top up of 6c.c of 0.125% bupivacaine and 
vitals were monitored. 
Number  of  supplementary  analgesic  doses  (6c.c  of  0.125% 
bupivacaine) required by each patient for period of 24 hours was noted in 
both  the  groups.  Occurrence  of  significant  side  effects  hypotension, 
bradycardia were noted. 
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OBSERVATIONS
STATISTICS AND ANALYSIS:
Forty patients posted for orthopaedic lower limb surgeries of ASA 
I & II were taken up for the study. They were allocated randomly in a 
double - blind fashion into two groups in equal number of 20 each. Group 
P (placebo) received a tablet of alike looking placebo(Vitamin C), Group 
G (Gabapentin) received 300mg tablet of  gabapentin 90 minutes prior to 
anaesthesia  .A  standard  anaesthetic  technique  was  followed  in  all 
patients. The patients were assessed by an observer in the postoperative 
period who was blinded for the group assignment. 
Data was expressed as mean + standard deviation (SD). Qualitative 
data  were  compared  with  chisquare  test.  Quantitative  variables  were 
compared with the student 't' test. the level of statistical significance was 
set at * P <0.05 and ** P < 0.01. 
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Demographic Profile: 
TABLE 1
PATIENT CHARACTERISTICS
S. 
No.
Parameters
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. Age (yrs) 35.10 ± 9.26 37.65 ± 11.60 0.447
2. Height (cms) 166.50 ± 4.72 166.30 ± 4.66 0.893 
3. Weight (kgs) 62.25 ± 6.41 62.80 ± 8.46 0.818
4. Duration of Surgery (hrs) 2.15 ± 0.09 2.15 ± 0.08 0.913
Thus  the  demographic  profile  and  Duration  of  Surgery  (hrs)  was 
comparable between the two groups. P value is not significant. 
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LIST OF ORTHOPAEDIC LOWER LIMB SURGERIES
        (ORIF -  Open Reduction and Internal Fixation)
S.
NO DIAGNOSIS AND SURGICAL 
PROCEDURES
  NO.OF CASES
GROUP P GROUP G
1 Fracture shaft of femur –ORIF  with 
interlocking nailing
9 11
2 Fracture neck of femur -- 
Hemiarthroplasty
4 5
3 Total hip replacement 2 1
4 Supracondylar fracture femur- ORIF 
with dynamic condylar screw(DCS)
7 3
TOTAL CASES 20 20
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TABLE 2
HEART RATE
S. 
No.
Parameters
(Minutes)
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. HR PRE – OP 101.70 ± 7.83 100.70 ± 8.54 0.702
2. HR10 96.05 ±  5.98 94.60 ± 6.59 0.471
3. HR20 90.80 ± 7.09 97.20 ± 6.60 0.465
4. HR30 87.55 ± 4.77 86.15 ± 4.11 0.326
5. HR40 86.45 ± 5.71 85.95 ± 5.31 0.776
6. HR50 85.10  ± 6.16 84.85 ± 6.71 0.903
7. HR60 85.05 ± 7.42 83.75 ± 7.44 0.583
8. HR70 83.90  ± 7.78 81.35 ± 7.24 0.290
9. HR80 82.95 ± 7.16 82.10 ± 6.88 0.704
10. HR90 82.95 ± 7.16 82.70 ± 7.98 0.917
11. HR100 84.25  ± 6.58 85.90 ± 6.98 0.447
12. HR110 88.40  ± 5.08 88.80 ± 4.96 0.802
13. HR120 92.00 ± 4.84 89.00 ± 4.59 0.052
14. HR130 90.85 ± 4.53 88.50 ± 3.09 0.063
15. HR140 91.50  ± 5.25 91.10 ± 5.28 0.811
16. HR150 96.40  ± 5.04 98.35 ± 6.23 0.283
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TABLE 3
SYSTOLIC BLOOD PRESSURE
S. 
No.
Parameters
(minutes)
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. SBP PRE-OP 129.25 ± 4.67 127.60 ± 4.52 0.263
2. SBP10 119.60  ± 3.91 118.35±4.79 0.372
3. SBP20 105.40 ±  6.24 102.30 ± 5.35 0.095
4. SBP30 108.45 ± 6.75 106.95 ± 6.38 0.474
5. SBP40 110.45 ± 6.56 113.10 ± 4.53 0.145
6. SBP50 112.85 ± 7.25 112.70 ± 6.10 0.944
7. SBP60 114.35 ± 4.86 114.20 ± 4.40 0.919
8. SBP70 113.25 ± 5.06 112.25 ± 4.92 0.530
9. SBP80 113.60 ± 5.39 115.50 ± 4.36 0.228
10. SBP90 112.65 ± 4.75 114.10 ± 3.84 0.295
11. SBP100 112.70 ± 6.58 108.35 ± 23.43 0.429
12. SBP110 118.15 ± 3.45 116.05 ± 4.65 0.113
13. SBP120 120.75 ± 4.69 119.75 ± 4.71 0.505
14. SBP130 116.60 ± 3.19 117.60 ± 3.22 0.330
15. SBP140 118.40 ± 5.47 119.40 ± 4.16 0.519
16. SBP150 124.80 ± 2.17 125.15 ± 2.48 0.637
39
FIGURE - 2
HR PRE - OP HR10 HR20 HR30 HR40 HR50 HR60
G
FIGURE - 3
PRESSURE
40
TABLE 4
DIASTOLIC BLOOD PRESSURE
S. 
No.
Parameters
(minutes)
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. DBP PRE-OP 83.15 ± 3.00 81.45 ± 2.96 0.079
2. DBP10 74.05 ± 4.65 72.9±4.33 0.423
3. DBP20 62.75 ± 6.62 61.7±5.72 0.600
4. DBP30 64.95 ± 6.69 63.70 ± 6.22 0.544
5. DBP40 67.60 ± 4.16 68.35 ± 4.89 0.604
6. DBP50 68.05 ± 5.09 67.70 ± 5.62 0.838
7. DBP60 70.45 ± 4.35 69.65 ± 4.31 0.562
8. DBP70 68.85 ± 5.35 67.40 ± 4.64 0.366
9. DBP80 69.45 ± 4.73 69.90 ± 4.39 0.757
10. DBP90 69.10 ± 3.71 69.15 ± 4.21 0.968
11. DBP100 69.35 ± 5.31 69.20 ± 6.35 0.936
12. DBP110 73.30 ± 3.63 72.45±4.55 0.213
13. DBP120 74.40 ± 5.17 73.65 ± 4.80 0.638
14. DBP130 72.05 ± 3.82 71.25 ± 3.96 0.519
15. DBP140 73.60 ± 5.83 73.70 ± 4.52 0.952
16. DBP150 79.15 ± 2.48 78.95 ± 3.72 0.342
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TABLE 5
MEAN ARTERIAL BLOOD PRESSURE
S. 
No.
Parameters
(minutes)
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. MAP PRE-OP 98.50 ± 3.33 96.35  ± 4.06 0.075
2. MAP10 89.10 ± 4.14 88.45±5.34 0.545
3. MAP20 77.00 ± 6.18 76.7±5.66 0.432
4. MAP30 79.35 ± 6.47 78.20 ± 6.08 0.566
5. MAP40 82.00 ± 4.50 83.30 ± 4.11 0.346
6. MAP50 82.95 ± 5.59 82.65 ± 5.52 0.865
7. MAP60 85.55 ± 5.09 84.65 ± 4.09 0.542
8. MAP70 83.60 ± 4.90 82.40 ± 4.48 0.424
9. MAP80 84.25 ± 4.63 85.15 ± 3.92 0.511
10. MAP90 84.55 ± 4.71 84.10 ± 3.73 0.739
11. MAP100 83.85 ± 5.47 84.35 ± 5.42 0.773
12. MAP110 88.50 ± 3.82 87.6±6.43    0.782
13. MAP120 89.70 ± 5.06 88.95 ± 4.45 0.622
14. MAP130 87.25 ± 3.01 86.90 ± 3.40 0.732
15. MAP140 88.10 ± 5.61 89.20 ± 3.89 0.475
16. MAP150 94.30 ± 2.36 94.30 ± 3.11 1.000
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Intraoperative  monitoring  of  heart  rate  (HR),  systolic  blood pressure 
(SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) between 
the two groups (Group P & Group G) were found to be insignificant in all of  
the  time  intervals..  This  demonstrates  that  the  hemodynamic  stability 
maintained in gabapentin group is as comparable to that of the hemodynamic 
stability maintained in placebo group throughout the intraoperative period. 
TABLE 6
RESPIRATORY RATE
S. 
No.
Parameters
(minutes)
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. RR PRE-OP 15.30 ± 1.13 15.15 ± 1.09 0.671
2. RR10 13.30 ± 1.22 14.15 ± 0.93 0.018*
3. RR20 13.90  ± 0.97 14.10 ± 1.12 0.549
4. RR30 12.75 ± 0.97 13.10 ± 0.97 0.260
5. RR40 12.45 ± 0.69 12.60 ± 0.75 0.515
6. RR50 12.65 ± 1.09 12.55 ± 0.76 0.738
7. RR60 13.00 ± 0.79 12.95 ± 0.69 0.833
8. RR70 13.45 ± 0.94 13.25 ± 0.85 0.486
9. RR80 12.80 ± 1.15 12.95 ± 1.05 0.669
10. RR90 12.95 ± 0.94 12.95 ± 0.89 1.000
11. RR100 13.10 ± 1.12 13.15 ± 1.09 0.887
12. RR110 13.20 ± 1.15 13.05 ± 1.15 0.682
13. RR120 13.15 ± 1.39 12.55 ± 0.83 0.105
14. RR130 13.05 ± 1.32 12.50 ± 1.00 0.145
15. RR140 13.90 ± 1.07 13.35 ± 0.93 0.092
16. RR150 14.95 ± 1.15 14.75 ± 1.22 0.508
* P < 0.05
44
FIGURE - 6
 RATE
FIGURE - 7
2 hrs 4 hrs 8 hrs 12 hrs 24 hrs
45
TABLE 7
PAIN SCORE  (VERBAL RATING SCALE)
S. 
No.
Parameters
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1. PS2 (hrs) 2.75±  0.44 0.00±  0.00 0.001**
2. PS4(hrs) 2.00±  0.46 0.45 ±  0.69 0.001**
3. PS8 (hrs) 2.15±  0.49 1.70 ±  0.57 0.011*
4. PS12 (hrs) 1.95± 0.69 1.50 ± 0.51 0.020*
5. PS24 (hrs) 1.85±  0.49 0.90 ±  0.31 0.001**
* P < 0.05 ** P < 0.01
The postoperative pain score (verbal rating scale) was found to be low at 
all time intervals (2,4, 8, 12, 24 Hrs ) in Group G when compared to group P. 
Significantly  low  pain  scores  were  observed  at  2,  4,  8,  12  and  24  hours 
intervals in patients belonging to group G (P < 0.01 at 2,  4,  8,  & 24 hours 
intervals & P <0.05 at 12 hours interval) than group P as shown in figure 7. The 
study demonstrated that pain relief was significantly better (P<0.05) in patients 
who received gabapentin pre emptively than the patients who received placebo. 
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TABLE 8
 TOTAL POST - OPERATIVE 
EPIDURAL TOP UP  REQUIREMENTS
S. 
No.
Parameters
Group
p valueGroup P Group G
Mean ± SD Mean ± SD
1 No. of supplementary 
analgesic doses (24 hrs) 
6.35±  0.49 4.25±  0.44 0.001**
                                              ** P < 0.01
Mean supplementary analgesic dose required in group G for 24 
hours -  4.25  ±  0.44 doses.  Mean supplementary analgesic dose required in 
group P for  24 hours -  6.35  ±  0.49 doses.  The demand for  supplementary 
analgesia over  24 hours was low in group G than group P with significant 
statistical difference (P<0.01). 
Chi-square test demonstrates no significant difference among both the 
groups regarding the incidence of side effects. (2 patients in Group P and 1 
patient in Group g developed hypotension).  No bradycardia was reported in 
either of the two groups. 
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DISCUSSION
        The present study was designed to evaluate the effectiveness 
of gabapentin as a preemptive analgesic in patients undergoing elective 
lower limb orthopaedic procedures under combined spinal epidural 
anaesthesia and evaluated the total number of epidural top up 
requirements for 24 hours and the occurance of any side effects to oral 
gabapentin A total of forty  patients were randomized into two groups (A 
& B) of 20 each. Group A received gabapentin while group B received 
vitamin C tablet. Both the groups were monitored for postoperative VRS, 
requirement of epidural top ups , heart rate,  blood pressure , headache 
and  dizziness
      Both the groups were comparable with respect to demographic details 
like age, sex,and  height of the patient. 
      In our study VRS and Epidural analgesic requirement in the 
postoperative period was found to be significantly lesser in gabapentin 
group compared to placebo group. Gabapentin with prolonged incubation 
in vitro decreases sustained firing of sodium dependent action potentials 
and suppresses discharges after nerve injury. Gabapentin also interacts 
with NMDA receptor complexes at the glycine site. Gabapentin has been 
found to decrease pain and prevent acute nociceptive and inflammatory 
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pain, when given before trauma34. Gabapentin has also been found to 
have anxiolytic property without amnestic effect27. The decrease in 
perioperative anxiety has been found to have a positive effect in 
decreasing postoperative pain and reduces postoperative opioid 
requirement. In our study gabapentin was given approximately 90 
minutes prior to surgery. Hussain (34)  et al observed gabapentin given 
approximately one and half  hours prior to surgery orally acquired a 
maximal plasma concentration level during the period of surgical stimuli, 
as it crosses the blood brain barrier rapidly and the concentration in the 
brain reaches that of the plasma. 
      In our study the mean VRS at "2" hour after surgery was 0(ZERO) in 
gabapentin group, while 2.4 (±0.44) in placebo group, the difference 
being highly significant (p<0.01). Similarly, the VRS were significantly 
higher in the placebo group at  4TH,  8th 12th and 24 hours with the mean at 
24th hour being 0.9(±0.31) in the gabapentin group and 1.85 (±0.49) in the 
placebo group. The differences being highly significant (p<0.01) at all 
hours. 
Anil Verma et al (37) had demonstrated the efficacy of oral gabapentin 
on post operative  pain scores. His study showed that the patients who 
received Gabapentin had significantly lower VAS scores compared to 
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those who received a placebo 
      Pandey C K et al 22,23 had demonstrated the efficacy of gabapentin on 
Post operative pain scores. Their study showed that patients who received 
gabapentin preemptively had lesser pain scores compared to the placebo 
group. Turan et al24, 32 had also demonstrated that preoperative oral 
gabapentin decreased postoperative pain scores and requirement of 
analgesics in patients undergoing abdominal hysterectomy. Dirks et al33 
found that even single dose of preoperative gabapentin resulted in 
substantial reduction in postoperative pain after radical mastectomy. 
Mengaux et al27 recorded the postoperative pain scores for 48 hours in 
knee surgeries and found that the VAS was significantly low and 
mobilization of limbs were better in gabapentin group compared to 
placebo. Rosarius et al35 demonstrated that a single dose of gabapentin 
given two and a half hours before induction of anesthesia reduced the 
need for postoperative pain medication by 40% during the first 20 
postoperative hours in patients undergoing vaginal hysterectomy. 
      Jorgean B Dhal et al36 in his publication has analyzed about 
preemptive analgesia and its efficacy in decreasing postoperative pain. He 
has also showed that by blocking the sensitization of the nociceptive 
signal preemptively by preoperative medications like gabapentin, NMDA 
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receptor antagonist and non-steroidal anti-inflammatory drugs reduces the 
development of the postoperative pain into chronic pain. 
      A number of hypotheses have been proposed in regard to the 
gabapentin opioid interaction, including those of inhibition of glutamate 
release, nitric oxide or postsynaptic calcium entry. In our study we 
observed that there was decreased requirement of postoperative rescue 
medication in the gabapentin group compared to the placebo group. The 
amount of the total epidural top up required by the gabapentin group was 
4.25 (±0.44) compared to 6.35(±0.49) used by the placebo group, with a 
significant p value.
Anil Verma et al (36) showed that the total epidural top up requirements 
for the first 24 hours in gabapentin group was 3.4±1.6 compared to the 
placebo group which required 5.6 ± 2.1.
                The results of our study correlate well with the above. 
Bradycardia with a heart rate < 60/ min was not encountered in any 
of the patient in both the groups. 
      Two patients of placebo group (10% of Group P) and one 
patient  of  gabapentin  group  (5%  of  Group  G)  had  episodes  of 
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hypotension with a MAP <65 mm Hg during intraoperative period who 
were managed with a single dose of ephedrine 6 mg IV and crystalloids.
           Postoperatively two patients of placebo group (10% of Group P) 
and one patient of gabapentin group (5% of Group V) had episodes of 
hypotension with a MAP <65 mm Hg. These patients were found to have 
an excessive blood loss seen in the operative wound drain, who are 
managed with compatible whole blood transfusion. No incidence of  any 
bradycardia was noted in both the groups during postoperative period.  
No incidence of headache and dizziness which are common with 
prolonged intake of  gabapentin was noted in any of the patients.
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SUMMARY
This double blind study was designed to evaluate the preemptive 
analgesic efficacy of gabapentin given 90 minutes prior to elective lower 
limb orthopaedic procedures under combined spinal epidural anaesthesia 
                       Forty ASA I & II patients undergoing elective orthopaedic 
lower limb surgical procedure under epidural anaesthesia were randomly 
allocated in a double blinded fashion of one of the two groups. Group P 
received  a  similar  looking  placebo  .Pain  was  assessed  using  a  verbal 
rating  scale  (VRS).  The  number  of  supplementary  analgesic  doses 
required for 24 hours were noted for the two groups. Pain score were 
significantly less in group G at 2, 4, 8, 12, 24 hours (P < 0.05) than in 
group  P,  after  surgery.  Overall  pain  score  over  24  hour  period  also 
revealed better pain relief in group G (P<0.05) as compared to Group P.
                 The  postoperative  analgesic  consumption  was  also 
significantly less in Group G (4.25 doses for 24 hours) than in Group P 
(6.35 doses for 24 hours). The incidence of hypotension did not differ 
significantly  between the two groups & with no reported case  of  any 
bradycardia  in  both  the  groups.  The  study  demonstrates  that  oral 
gabapentin  given 90 minutes  before  surgery  would  improve  analgesic 
quality and reduce postoperative analgesic consumption without any 
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hemodynamic instability. There was no headache or dizziness in any of 
the patients who received oral gabapentin which shows the pre emptive 
analgesic efficacy is with out any major side effects.
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CONCLUSION
1. Single dose oral  administration of  gabapentin as  pre emptive 
analgesic  effectively  reduces  the  post  operative  epidural 
analgesia  requirements  in  patients  undergoing  elective 
orthopaedic lower limb surgeries. 
2. Oral  gabapentin  has  no  effect  on  the  hemodynamics  of  the 
patient
3. No side effects were noted with a single dose of oral gabapentin
56
BIBLIOGRAPHY:
1.)         Fishman S, Borsook D. Opioids in pain management. 
In: Benzon H, Raja S,    Molloy RE, Strichartz G, eds. Essentials 
of pain medicine and regional anesthesia. New York: Churchill 
Livingstone, 1999:51-4. 
2.)         Wu CT, Yu. JC, Yeh CC, et al. Preincisional 
dextromethorphan treatment decreases postoperative pain and 
opioid requirement after laparoscopic cholecystectomy. 
Anesthesia Analgesia 1999; 88: 1331-4. 
3.)         Woolf CJ, Chong MS. Preemptive analgesia-treating 
postoperative pain by preventing the establishment of central 
sensitization. Anesthesia Analgesia 1993; 77: 362-79. 
4.)         Abdi S, Lee DH, Chung JM. The anti-allodynic effects 
of amitriptyline, gabapentin, and lidocaine in a rat model of 
neuropathic pain. Anesthesia Analgesia 1998; 87: 1360-6. 
5.)        Dirks J, Petersen KL, Rowbotham MC, Dahl JB. 
Gabapentin suppresses cutaneous hyperalgesia following 
heat/capsaicin sensitization. Anesthesiology 2002; 97: 102-6. 
6.)        Christopher L Wu, John C.Rowlingson Acute 
postoperative pain and chronic pain. In: Ronald Miller, 6th Ed 
Miller's anaesthesia, 2005:2729-2765. 
7.)         James D.Me Namara. Pharmacotherapy of epilepsy. In: 
Goodman and Gilman's 11thEd Pharmacological basics of 
therapeutics 2005:517. 
57
8.)           Christine N Sang and Karla S Hayer. Anticonvulscent 
medications in neuropathic pain .In: Wall and Melzack's 5th Ed 
Text book of pain 2006:502-504. 
9.)            Taylor CP, Gee NS et al, A summary of mechanistic 
hypotheses of gabapentin. Epilepsy Research 1998; 29:233-249. 
10.) Goldust A, Su T Z et al, Effects of anticonvulscent 
drug, gabapentin (neurontin), binds to alpha 2delta subunit of a 
calcium channel. Journal of Biological chemistry 1995; 
271:5768-5776. 
11.) Gee N S, Brown J P et al. The novel anticolvulsant 
drug gabapentin (neurontin) binds to alpha 2 delta subunit of a 
calcium channel. Journal of Biological chemistry 1996; 
271:5768-5776. 
12.) Marais E,Klugbauer N, Hofmann F 2001 calcium 
channel alpha 2 theta subunits -structure and gabapentin 
binding .Molecular pharmacology 2001; 59(5):1243-1248. 
13.) Suton K G, Martin D J, Pinnock R D. Gabapentin 
inhibits high threshold calcium channel currents in cultured rat 
dorsal root ganglion neurons. British Journal of Pharmacology 
2002; 135(1): 257-265. 
14.) Malmberg A B,Yaksh T L, Voltage-sensitive calcium 
channels in spinal nociceptive processing ,blockade of N-and P-
type channels inhibits formalin induced nociception , Journal of 
Neuroscience 1994;14:4882-4890. 
58
15.) Mac Donald R L and Greenfield L J .Mechanisms of 
action of new antiepileptic drugs. Current opinion in Neurology, 
1997; 10:121-128. 
16.) Macdonald R L, and Kelly, K M Antiepileptic drug 
mechanisms of action. Epilepsia, 1993; 34 (suppl 5):51-58. 
17.) Rowbotham M, Harden N Gabapentin for the 
treatment of postherpetic neuralgia. A randomized controlled 
trial. Journal of American Medical Association 1998; 280:1837-
1842. 
18.) Gorson K C, Schott C Gabapentin in treatment of 
painful diabetic neuropathy: a placebo controlled, double blind, 
crossover trial. Journal of neurology, Neurosurgery and 
Psychiatric 1999; 66:251-252. 
19.) Pandey C K, Bose N, Gabapentin for the treatment of 
pain in Guillian-barre syndrome: a double-blind, placebo-
controlled, crossover study Anaesthesia and Analgesia 2002; 95: 
1719-1723. 
20.) Van de Vusse A, Stompden Berg SGM, Kesseis A 
HF, Randomized controlled trial of gabapentin in complex 
regional pain syndrome typel.BMC Neurology 2004; 4:13. 
21.) Bone M, Crithchiey P Gabapentin in post amputation 
phantom limb pain: a randomized, double blind, placebo-
controlled, cross-over study. Regional Anaesthesia and pain 
medicine 2002; 27:481-486. 
59
22.) Pandey CK et al. Preemptive use of Gabapentin 
significantly decreases postoperative pain and rescue analgesic 
requirement in laparoscopic cholecystectomy, Canadian Journal 
of Anaethesia2004; 51: 358-363. 
23.) Pandey CK et al. Preemptive Gabapentin decreases 
postoperative pain after lumbar discoidectomy .Canadian Journal 
of Anaesthesia 2004; 52: 986 -989. 
24.) Turan et al .The analgesic effect of Gabapentin after 
total abdominal hysterectomy Anesthesia and Analgesia 2004; 
98: 137-1373. 
25.) Monazori et al. Preemptive Gabapentin significantly 
reduces postoperative pain and morphine demand following 
lower extremity orthopedic surgery. Singapore medjournal 2007, 
48(8): 748. 
26.) Drumus M et al. The postoperative analgesic effects 
of a combination of Gabapentin and Paracetamol in patients 
undergoing abdominal hysterectomy, A randomized clinical trial, 
Acta Anaesthesiologica scandivinavica,2007; 51(3): 299-34. 
27.) Menigaux C et al The preoperative Gabapentin 
decreases anxiety and improves early functional recovery from 
knee surgery. Anaesthesia and analgesia 2005; 100:1394-1399. 
28.) Tiippana E M et al Do surgical patients benefit from 
preoperative Gabapentin /Pregabalin? A systematic review of 
60
efficacy and safety Anesthesia and Analgesia 2007; 104: 1545 
-1556. 
29.) Dierking G et al Effects of Gabapentin on 
postoperative morphine consumption and pain after abdominal 
hysterectomy. A randomized double blind study Acta 
Anaesthesiologica scandinavica, 2004; 48: 322-327. 
30.) Mikkelsen S et al The effect of Gabapentin on 
postoperative pain following tonsillectomy adults -Acta 
Anesthesiologica Scandinavia,2006; 50: 809-815. 
31.) Fassoulakki A et al Gabapentin attenuates late but not 
acute pain after abdominal hysterectomy. European journal of 
anesthesiology 2006, 23:136-141. 
32.) Turan et al Premedication of Gabapentin the effect on 
the tourniquet pain and quality of lYRA, Anesthesia analgesia 
2007 Jan: 104(1):97101. 
33.) Dirks. et al A randomized study of the effects of 
single dose gabapentin versus placebo on postoperative pain and 
morphine consumption after mastectomy, Anesthesiology, 2002; 
97: 560-564. 
34.) Hussain AI-Mujadi.Preemptive gabapentin reduces 
postoperative pain and opioid demand following thyroid surgery, 
Canadian Journal of Anaesthesia 2006; 53: 268-273 
61
35.) Rorarius MG, Mennander S, Suominen P, et al. 
Gabapentin for the prevention of postoperative pain after vaginal 
hysterectomy. Pain 2004; 110: 175-181. 
36.) Jorgean B. Dhal et al. Preemptive analgesia, British 
Medical Bulletin 2004; 71:13-27. 
37.) To Evaluate the Role of Gabapentin as Preemptive 
Analgesic in Patients Undergoing Total Abdominal 
Hysterectomy in Epidural Anaesthesia  Anil Verma, Sangeeta 
Arya, Sandeep Sahu, Indu Lata, H D Pandey, Harpreet Singh 
2008 52(4) 428-431
38.) Rodgers A, Walker N, Schug S, reduction of postop 
mortality and morbidity with epidural or spinal anaesthesia:BMJ 
321:1493,2000.
 
62
